nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA4—autonomic nervous system—type 2 diabetes mellitus	0.0152	0.199	CbGeAlD
Varenicline—CHRNA4—peripheral nervous system—type 2 diabetes mellitus	0.011	0.143	CbGeAlD
Varenicline—CHRNA4—nerve—type 2 diabetes mellitus	0.00857	0.112	CbGeAlD
Varenicline—CHRNB2—islet of Langerhans—type 2 diabetes mellitus	0.00664	0.0866	CbGeAlD
Varenicline—CHRNA3—retina—type 2 diabetes mellitus	0.0055	0.0718	CbGeAlD
Varenicline—CHRNB2—nephron tubule—type 2 diabetes mellitus	0.00535	0.0697	CbGeAlD
Varenicline—CHRNB2—cortex of kidney—type 2 diabetes mellitus	0.00458	0.0597	CbGeAlD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00437	0.0299	CbGpPWpGaD
Varenicline—CHRNB2—adipose tissue—type 2 diabetes mellitus	0.00423	0.0552	CbGeAlD
Varenicline—CHRNA7—retina—type 2 diabetes mellitus	0.0036	0.0469	CbGeAlD
Varenicline—CHRNA7—cardiovascular system—type 2 diabetes mellitus	0.00304	0.0397	CbGeAlD
Varenicline—CHRNB2—Circadian rythm related genes—CARTPT—type 2 diabetes mellitus	0.00303	0.0208	CbGpPWpGaD
Varenicline—CHRNA4—cardiovascular system—type 2 diabetes mellitus	0.003	0.0391	CbGeAlD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00299	0.0205	CbGpPWpGaD
Varenicline—CHRNA7—kidney—type 2 diabetes mellitus	0.00298	0.0388	CbGeAlD
Varenicline—CHRNB2—liver—type 2 diabetes mellitus	0.00297	0.0387	CbGeAlD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00282	0.0193	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PROX1—type 2 diabetes mellitus	0.0027	0.0185	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AGRP—type 2 diabetes mellitus	0.0027	0.0185	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00243	0.0167	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00236	0.0162	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.0023	0.0157	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AANAT—type 2 diabetes mellitus	0.00216	0.0148	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PTGDS—type 2 diabetes mellitus	0.00216	0.0148	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00213	0.0146	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00213	0.0146	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00208	0.0142	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—MTNR1A—type 2 diabetes mellitus	0.00196	0.0134	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00192	0.0132	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PAX4—type 2 diabetes mellitus	0.00174	0.0119	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00164	0.0112	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00157	0.0107	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00157	0.0107	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNK16—type 2 diabetes mellitus	0.0015	0.0103	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—STAR—type 2 diabetes mellitus	0.00148	0.0101	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00146	0.00999	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00146	0.00999	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00144	0.00988	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00142	0.00974	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00142	0.0097	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00128	0.00876	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00125	0.00854	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—ABCC8—type 2 diabetes mellitus	0.00124	0.0085	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—HNF1B—type 2 diabetes mellitus	0.00121	0.00827	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00119	0.00814	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00119	0.00814	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00116	0.00794	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00112	0.00768	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—ABCC8—type 2 diabetes mellitus	0.00109	0.00748	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00109	0.00748	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GAD2—type 2 diabetes mellitus	0.00108	0.00743	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00104	0.00711	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PRKAA1—type 2 diabetes mellitus	0.00104	0.0071	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—MTNR1B—type 2 diabetes mellitus	0.00103	0.00703	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000985	0.00675	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000981	0.00672	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00098	0.00671	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GAD2—type 2 diabetes mellitus	0.000955	0.00654	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CPT1A—type 2 diabetes mellitus	0.000915	0.00627	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000912	0.00625	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000907	0.00621	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NAMPT—type 2 diabetes mellitus	0.000898	0.00615	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000898	0.00615	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000864	0.00592	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000852	0.00583	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—F7—type 2 diabetes mellitus	0.000851	0.00583	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000808	0.00554	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000803	0.0055	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000803	0.0055	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SREBF1—type 2 diabetes mellitus	0.0008	0.00548	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000799	0.00547	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000787	0.00539	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000783	0.00537	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000777	0.00532	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000766	0.00525	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GHRL—type 2 diabetes mellitus	0.000758	0.00519	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000747	0.00511	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000747	0.00511	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ADIPOQ—type 2 diabetes mellitus	0.000735	0.00503	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000732	0.00502	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000732	0.00502	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000722	0.00495	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000712	0.00487	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000699	0.00479	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000695	0.00476	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000694	0.00476	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GAD2—type 2 diabetes mellitus	0.000688	0.00471	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000682	0.00467	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00067	0.00459	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000653	0.00447	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GAD2—type 2 diabetes mellitus	0.000653	0.00447	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000628	0.0043	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000624	0.00428	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000622	0.00426	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000615	0.00422	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000612	0.00419	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000609	0.00417	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000609	0.00417	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000608	0.00416	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.0006	0.00411	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARGC1A—type 2 diabetes mellitus	0.000598	0.0041	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00059	0.00404	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AVP—type 2 diabetes mellitus	0.00059	0.00404	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	0.000578	0.00396	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000578	0.00396	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000575	0.00394	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000575	0.00394	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000572	0.00392	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000549	0.00376	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000546	0.00374	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000546	0.00374	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000535	0.00367	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000535	0.00366	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GAD2—type 2 diabetes mellitus	0.000532	0.00364	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000531	0.00364	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GNB3—type 2 diabetes mellitus	0.000522	0.00358	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000522	0.00358	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000512	0.00351	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.0005	0.00343	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.0005	0.00343	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—FAS—type 2 diabetes mellitus	0.000497	0.00341	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000494	0.00338	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000491	0.00336	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000486	0.00333	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000481	0.0033	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	0.000481	0.00329	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000466	0.00319	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GNB3—type 2 diabetes mellitus	0.00046	0.00315	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00046	0.00315	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—LEP—type 2 diabetes mellitus	0.000456	0.00313	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000447	0.00306	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000445	0.00305	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000443	0.00304	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.00044	0.00302	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000436	0.00299	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000433	0.00296	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000432	0.00296	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000432	0.00296	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000429	0.00294	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	0.000425	0.00291	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000421	0.00288	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000418	0.00286	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000414	0.00283	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.00041	0.00281	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00041	0.00281	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000408	0.00279	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000408	0.00279	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000402	0.00276	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CALM1—type 2 diabetes mellitus	0.0004	0.00274	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	0.000397	0.00272	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000396	0.00272	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000393	0.00269	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000391	0.00268	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000385	0.00264	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000376	0.00258	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000366	0.0025	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	0.000358	0.00245	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000355	0.00243	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CALM1—type 2 diabetes mellitus	0.000352	0.00241	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.00035	0.0024	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000343	0.00235	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000341	0.00233	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000334	0.00229	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000332	0.00228	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GNB3—type 2 diabetes mellitus	0.000331	0.00227	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000331	0.00227	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000331	0.00227	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.00032	0.00219	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000319	0.00218	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GNB3—type 2 diabetes mellitus	0.000314	0.00215	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000314	0.00215	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000311	0.00213	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000302	0.00207	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000298	0.00204	CbGpPWpGaD
Varenicline—Angioedema—Losartan—type 2 diabetes mellitus	0.000296	0.000381	CcSEcCtD
Varenicline—Infection—Metformin—type 2 diabetes mellitus	0.000296	0.00038	CcSEcCtD
Varenicline—Insomnia—Valsartan—type 2 diabetes mellitus	0.000296	0.00038	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000295	0.00202	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000295	0.00202	CbGpPWpGaD
Varenicline—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000294	0.000379	CcSEcCtD
Varenicline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000293	0.000377	CcSEcCtD
Varenicline—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000293	0.000377	CcSEcCtD
Varenicline—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000293	0.000377	CcSEcCtD
Varenicline—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000293	0.000377	CcSEcCtD
Varenicline—Shock—Metformin—type 2 diabetes mellitus	0.000293	0.000377	CcSEcCtD
Varenicline—Insomnia—Orlistat—type 2 diabetes mellitus	0.000292	0.000376	CcSEcCtD
Varenicline—Malaise—Losartan—type 2 diabetes mellitus	0.000292	0.000376	CcSEcCtD
Varenicline—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000292	0.000376	CcSEcCtD
Varenicline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000292	0.000376	CcSEcCtD
Varenicline—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000292	0.000376	CcSEcCtD
Varenicline—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000291	0.000375	CcSEcCtD
Varenicline—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000291	0.000375	CcSEcCtD
Varenicline—Vertigo—Losartan—type 2 diabetes mellitus	0.000291	0.000374	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000291	0.000374	CcSEcCtD
Varenicline—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000291	0.000374	CcSEcCtD
Varenicline—Somnolence—Valsartan—type 2 diabetes mellitus	0.000291	0.000374	CcSEcCtD
Varenicline—Syncope—Losartan—type 2 diabetes mellitus	0.00029	0.000374	CcSEcCtD
Varenicline—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00029	0.000372	CcSEcCtD
Varenicline—Skin disorder—Metformin—type 2 diabetes mellitus	0.000289	0.000372	CcSEcCtD
Varenicline—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000288	0.000371	CcSEcCtD
Varenicline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000288	0.00037	CcSEcCtD
Varenicline—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000288	0.00037	CcSEcCtD
Varenicline—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000288	0.00037	CcSEcCtD
Varenicline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000287	0.000369	CcSEcCtD
Varenicline—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000287	0.000369	CcSEcCtD
Varenicline—Palpitations—Losartan—type 2 diabetes mellitus	0.000286	0.000368	CcSEcCtD
Varenicline—Nausea—Glimepiride—type 2 diabetes mellitus	0.000285	0.000367	CcSEcCtD
Varenicline—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000285	0.000367	CcSEcCtD
Varenicline—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000285	0.000366	CcSEcCtD
Varenicline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000284	0.000366	CcSEcCtD
Varenicline—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000284	0.000366	CcSEcCtD
Varenicline—Asthenia—Glyburide—type 2 diabetes mellitus	0.000284	0.000366	CcSEcCtD
Varenicline—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000284	0.000366	CcSEcCtD
Varenicline—Anorexia—Metformin—type 2 diabetes mellitus	0.000284	0.000365	CcSEcCtD
Varenicline—Cough—Losartan—type 2 diabetes mellitus	0.000283	0.000364	CcSEcCtD
Varenicline—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000283	0.000364	CcSEcCtD
Varenicline—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000282	0.000363	CcSEcCtD
Varenicline—Fatigue—Valsartan—type 2 diabetes mellitus	0.000282	0.000363	CcSEcCtD
Varenicline—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000281	0.000362	CcSEcCtD
Varenicline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000281	0.000362	CcSEcCtD
Varenicline—Oedema—Irbesartan—type 2 diabetes mellitus	0.000281	0.000361	CcSEcCtD
Varenicline—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000281	0.000361	CcSEcCtD
Varenicline—Pruritus—Glyburide—type 2 diabetes mellitus	0.00028	0.000361	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00028	0.00192	CbGpPWpGaD
Varenicline—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00028	0.00036	CcSEcCtD
Varenicline—Constipation—Valsartan—type 2 diabetes mellitus	0.00028	0.00036	CcSEcCtD
Varenicline—Infection—Irbesartan—type 2 diabetes mellitus	0.000279	0.000359	CcSEcCtD
Varenicline—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000279	0.000359	CcSEcCtD
Varenicline—Fatigue—Orlistat—type 2 diabetes mellitus	0.000278	0.000358	CcSEcCtD
Varenicline—Hypotension—Metformin—type 2 diabetes mellitus	0.000278	0.000358	CcSEcCtD
Varenicline—Erythema—Ramipril—type 2 diabetes mellitus	0.000278	0.000357	CcSEcCtD
Varenicline—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000278	0.000357	CcSEcCtD
Varenicline—Shock—Irbesartan—type 2 diabetes mellitus	0.000276	0.000356	CcSEcCtD
Varenicline—Pain—Orlistat—type 2 diabetes mellitus	0.000276	0.000355	CcSEcCtD
Varenicline—Chest pain—Losartan—type 2 diabetes mellitus	0.000276	0.000355	CcSEcCtD
Varenicline—Myalgia—Losartan—type 2 diabetes mellitus	0.000276	0.000355	CcSEcCtD
Varenicline—Arthralgia—Losartan—type 2 diabetes mellitus	0.000276	0.000355	CcSEcCtD
Varenicline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000276	0.000354	CcSEcCtD
Varenicline—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000275	0.000354	CcSEcCtD
Varenicline—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000275	0.000354	CcSEcCtD
Varenicline—Anxiety—Losartan—type 2 diabetes mellitus	0.000275	0.000354	CcSEcCtD
Varenicline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000274	0.000353	CcSEcCtD
Varenicline—Rash—Bromocriptine—type 2 diabetes mellitus	0.000273	0.000352	CcSEcCtD
Varenicline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000273	0.000351	CcSEcCtD
Varenicline—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000273	0.000351	CcSEcCtD
Varenicline—Discomfort—Losartan—type 2 diabetes mellitus	0.000272	0.00035	CcSEcCtD
Varenicline—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000272	0.00035	CcSEcCtD
Varenicline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000272	0.000349	CcSEcCtD
Varenicline—Headache—Bromocriptine—type 2 diabetes mellitus	0.000272	0.000349	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000271	0.000349	CcSEcCtD
Varenicline—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000271	0.000349	CcSEcCtD
Varenicline—Dry mouth—Losartan—type 2 diabetes mellitus	0.00027	0.000347	CcSEcCtD
Varenicline—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000268	0.000344	CcSEcCtD
Varenicline—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000267	0.000344	CcSEcCtD
Varenicline—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000267	0.000344	CcSEcCtD
Varenicline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000266	0.000342	CcSEcCtD
Varenicline—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000265	0.000341	CcSEcCtD
Varenicline—Somnolence—Metformin—type 2 diabetes mellitus	0.000265	0.00034	CcSEcCtD
Varenicline—Oedema—Losartan—type 2 diabetes mellitus	0.000264	0.00034	CcSEcCtD
Varenicline—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000264	0.00034	CcSEcCtD
Varenicline—Infection—Losartan—type 2 diabetes mellitus	0.000263	0.000338	CcSEcCtD
Varenicline—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000262	0.000338	CcSEcCtD
Varenicline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000262	0.000337	CcSEcCtD
Varenicline—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000262	0.000337	CcSEcCtD
Varenicline—Tremor—Ramipril—type 2 diabetes mellitus	0.00026	0.000335	CcSEcCtD
Varenicline—Shock—Losartan—type 2 diabetes mellitus	0.00026	0.000335	CcSEcCtD
Varenicline—Urticaria—Valsartan—type 2 diabetes mellitus	0.00026	0.000334	CcSEcCtD
Varenicline—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000259	0.000334	CcSEcCtD
Varenicline—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000259	0.000333	CcSEcCtD
Varenicline—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000259	0.000333	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000259	0.00177	CbGpPWpGaD
Varenicline—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000258	0.000332	CcSEcCtD
Varenicline—Tachycardia—Losartan—type 2 diabetes mellitus	0.000258	0.000332	CcSEcCtD
Varenicline—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000258	0.000332	CcSEcCtD
Varenicline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000257	0.000331	CcSEcCtD
Varenicline—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000257	0.000331	CcSEcCtD
Varenicline—Fatigue—Metformin—type 2 diabetes mellitus	0.000257	0.00033	CcSEcCtD
Varenicline—Urticaria—Orlistat—type 2 diabetes mellitus	0.000257	0.00033	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—GNB3—type 2 diabetes mellitus	0.000256	0.00175	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000256	0.00175	CbGpPWpGaD
Varenicline—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000256	0.000329	CcSEcCtD
Varenicline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000256	0.000329	CcSEcCtD
Varenicline—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000255	0.000328	CcSEcCtD
Varenicline—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000255	0.000328	CcSEcCtD
Varenicline—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000255	0.000328	CcSEcCtD
Varenicline—Agitation—Ramipril—type 2 diabetes mellitus	0.000255	0.000328	CcSEcCtD
Varenicline—Constipation—Metformin—type 2 diabetes mellitus	0.000255	0.000327	CcSEcCtD
Varenicline—Angioedema—Ramipril—type 2 diabetes mellitus	0.000254	0.000326	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—CALM1—type 2 diabetes mellitus	0.000254	0.00174	CbGpPWpGaD
Varenicline—Anorexia—Losartan—type 2 diabetes mellitus	0.000252	0.000324	CcSEcCtD
Varenicline—Vomiting—Glyburide—type 2 diabetes mellitus	0.000252	0.000324	CcSEcCtD
Varenicline—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000252	0.000324	CcSEcCtD
Varenicline—Malaise—Ramipril—type 2 diabetes mellitus	0.00025	0.000322	CcSEcCtD
Varenicline—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00025	0.000322	CcSEcCtD
Varenicline—Rash—Glyburide—type 2 diabetes mellitus	0.00025	0.000321	CcSEcCtD
Varenicline—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00025	0.000321	CcSEcCtD
Varenicline—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00025	0.000321	CcSEcCtD
Varenicline—Vertigo—Ramipril—type 2 diabetes mellitus	0.00025	0.000321	CcSEcCtD
Varenicline—Syncope—Ramipril—type 2 diabetes mellitus	0.000249	0.00032	CcSEcCtD
Varenicline—Headache—Glyburide—type 2 diabetes mellitus	0.000248	0.000319	CcSEcCtD
Varenicline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000247	0.000318	CcSEcCtD
Varenicline—Hypotension—Losartan—type 2 diabetes mellitus	0.000247	0.000318	CcSEcCtD
Varenicline—Palpitations—Ramipril—type 2 diabetes mellitus	0.000245	0.000316	CcSEcCtD
Varenicline—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000245	0.000316	CcSEcCtD
Varenicline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000244	0.000314	CcSEcCtD
Varenicline—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000244	0.000314	CcSEcCtD
Varenicline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000243	0.000313	CcSEcCtD
Varenicline—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000243	0.000313	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000243	0.00166	CbGpPWpGaD
Varenicline—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000243	0.000312	CcSEcCtD
Varenicline—Cough—Ramipril—type 2 diabetes mellitus	0.000242	0.000312	CcSEcCtD
Varenicline—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000242	0.000312	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000241	0.00031	CcSEcCtD
Varenicline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000241	0.00031	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—CALM1—type 2 diabetes mellitus	0.000241	0.00165	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000241	0.00165	CbGpPWpGaD
Varenicline—Convulsion—Ramipril—type 2 diabetes mellitus	0.000241	0.00031	CcSEcCtD
Varenicline—Constipation—Irbesartan—type 2 diabetes mellitus	0.00024	0.000309	CcSEcCtD
Varenicline—Pain—Irbesartan—type 2 diabetes mellitus	0.00024	0.000309	CcSEcCtD
Varenicline—Insomnia—Losartan—type 2 diabetes mellitus	0.000239	0.000308	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000238	0.00163	CbGpPWpGaD
Varenicline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000238	0.000306	CcSEcCtD
Varenicline—Urticaria—Metformin—type 2 diabetes mellitus	0.000236	0.000304	CcSEcCtD
Varenicline—Myalgia—Ramipril—type 2 diabetes mellitus	0.000236	0.000304	CcSEcCtD
Varenicline—Chest pain—Ramipril—type 2 diabetes mellitus	0.000236	0.000304	CcSEcCtD
Varenicline—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000236	0.000304	CcSEcCtD
Varenicline—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000236	0.000303	CcSEcCtD
Varenicline—Anxiety—Ramipril—type 2 diabetes mellitus	0.000236	0.000303	CcSEcCtD
Varenicline—Nausea—Glyburide—type 2 diabetes mellitus	0.000235	0.000303	CcSEcCtD
Varenicline—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000235	0.000303	CcSEcCtD
Varenicline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000235	0.000303	CcSEcCtD
Varenicline—Somnolence—Losartan—type 2 diabetes mellitus	0.000235	0.000302	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000235	0.000302	CcSEcCtD
Varenicline—Asthenia—Valsartan—type 2 diabetes mellitus	0.000235	0.000302	CcSEcCtD
Varenicline—Discomfort—Ramipril—type 2 diabetes mellitus	0.000234	0.000301	CcSEcCtD
Varenicline—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000233	0.000299	CcSEcCtD
Varenicline—Asthenia—Orlistat—type 2 diabetes mellitus	0.000232	0.000298	CcSEcCtD
Varenicline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000231	0.000298	CcSEcCtD
Varenicline—Pruritus—Valsartan—type 2 diabetes mellitus	0.000231	0.000297	CcSEcCtD
Varenicline—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000231	0.000297	CcSEcCtD
Varenicline—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00023	0.000296	CcSEcCtD
Varenicline—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00023	0.000295	CcSEcCtD
Varenicline—Pruritus—Orlistat—type 2 diabetes mellitus	0.000229	0.000294	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000228	0.00156	CbGpPWpGaD
Varenicline—Fatigue—Losartan—type 2 diabetes mellitus	0.000228	0.000293	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000227	0.00156	CbGpPWpGaD
Varenicline—Oedema—Ramipril—type 2 diabetes mellitus	0.000227	0.000292	CcSEcCtD
Varenicline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000226	0.000291	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000226	0.00155	CbGpPWpGaD
Varenicline—Constipation—Losartan—type 2 diabetes mellitus	0.000226	0.000291	CcSEcCtD
Varenicline—Pain—Losartan—type 2 diabetes mellitus	0.000226	0.000291	CcSEcCtD
Varenicline—Rash—Gliclazide—type 2 diabetes mellitus	0.000224	0.000289	CcSEcCtD
Varenicline—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000224	0.000288	CcSEcCtD
Varenicline—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000224	0.000288	CcSEcCtD
Varenicline—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000223	0.000287	CcSEcCtD
Varenicline—Shock—Ramipril—type 2 diabetes mellitus	0.000223	0.000287	CcSEcCtD
Varenicline—Headache—Gliclazide—type 2 diabetes mellitus	0.000223	0.000287	CcSEcCtD
Varenicline—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000222	0.000286	CcSEcCtD
Varenicline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000222	0.000286	CcSEcCtD
Varenicline—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000222	0.000286	CcSEcCtD
Varenicline—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000222	0.000286	CcSEcCtD
Varenicline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000221	0.000285	CcSEcCtD
Varenicline—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000221	0.000284	CcSEcCtD
Varenicline—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00022	0.000283	CcSEcCtD
Varenicline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000219	0.000282	CcSEcCtD
Varenicline—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000218	0.00028	CcSEcCtD
Varenicline—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000216	0.000278	CcSEcCtD
Varenicline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000216	0.000278	CcSEcCtD
Varenicline—Anorexia—Ramipril—type 2 diabetes mellitus	0.000216	0.000278	CcSEcCtD
Varenicline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000214	0.000275	CcSEcCtD
Varenicline—Asthenia—Metformin—type 2 diabetes mellitus	0.000214	0.000275	CcSEcCtD
Varenicline—Hypotension—Ramipril—type 2 diabetes mellitus	0.000212	0.000272	CcSEcCtD
Varenicline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000211	0.000272	CcSEcCtD
Varenicline—Pruritus—Metformin—type 2 diabetes mellitus	0.000211	0.000271	CcSEcCtD
Varenicline—Urticaria—Losartan—type 2 diabetes mellitus	0.00021	0.00027	CcSEcCtD
Varenicline—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000209	0.000269	CcSEcCtD
Varenicline—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000209	0.000269	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000209	0.00143	CbGpPWpGaD
Varenicline—Vomiting—Valsartan—type 2 diabetes mellitus	0.000208	0.000267	CcSEcCtD
Varenicline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000207	0.000266	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000207	0.000266	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000206	0.00141	CbGpPWpGaD
Varenicline—Rash—Valsartan—type 2 diabetes mellitus	0.000206	0.000265	CcSEcCtD
Varenicline—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000206	0.000265	CcSEcCtD
Varenicline—Vomiting—Orlistat—type 2 diabetes mellitus	0.000205	0.000264	CcSEcCtD
Varenicline—Insomnia—Ramipril—type 2 diabetes mellitus	0.000205	0.000264	CcSEcCtD
Varenicline—Headache—Valsartan—type 2 diabetes mellitus	0.000205	0.000263	CcSEcCtD
Varenicline—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000204	0.000262	CcSEcCtD
Varenicline—Rash—Orlistat—type 2 diabetes mellitus	0.000204	0.000262	CcSEcCtD
Varenicline—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000203	0.000262	CcSEcCtD
Varenicline—Headache—Orlistat—type 2 diabetes mellitus	0.000202	0.00026	CcSEcCtD
Varenicline—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000202	0.00026	CcSEcCtD
Varenicline—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000202	0.000259	CcSEcCtD
Varenicline—Somnolence—Ramipril—type 2 diabetes mellitus	0.000202	0.000259	CcSEcCtD
Varenicline—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.0002	0.000257	CcSEcCtD
Varenicline—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000199	0.000256	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000198	0.00136	CbGpPWpGaD
Varenicline—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000197	0.000253	CcSEcCtD
Varenicline—Dizziness—Metformin—type 2 diabetes mellitus	0.000197	0.000253	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—CALM1—type 2 diabetes mellitus	0.000196	0.00134	CbGpPWpGaD
Varenicline—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000196	0.000252	CcSEcCtD
Varenicline—Fatigue—Ramipril—type 2 diabetes mellitus	0.000195	0.000251	CcSEcCtD
Varenicline—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000195	0.000251	CcSEcCtD
Varenicline—Nausea—Valsartan—type 2 diabetes mellitus	0.000194	0.00025	CcSEcCtD
Varenicline—Constipation—Ramipril—type 2 diabetes mellitus	0.000194	0.000249	CcSEcCtD
Varenicline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000192	0.000247	CcSEcCtD
Varenicline—Nausea—Orlistat—type 2 diabetes mellitus	0.000192	0.000247	CcSEcCtD
Varenicline—Asthenia—Losartan—type 2 diabetes mellitus	0.00019	0.000244	CcSEcCtD
Varenicline—Vomiting—Metformin—type 2 diabetes mellitus	0.000189	0.000243	CcSEcCtD
Varenicline—Rash—Metformin—type 2 diabetes mellitus	0.000188	0.000241	CcSEcCtD
Varenicline—Dermatitis—Metformin—type 2 diabetes mellitus	0.000188	0.000241	CcSEcCtD
Varenicline—Pruritus—Losartan—type 2 diabetes mellitus	0.000187	0.000241	CcSEcCtD
Varenicline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000187	0.00024	CcSEcCtD
Varenicline—Headache—Metformin—type 2 diabetes mellitus	0.000186	0.00024	CcSEcCtD
Varenicline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000186	0.000239	CcSEcCtD
Varenicline—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000185	0.000238	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000185	0.00127	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000184	0.00126	CbGpPWpGaD
Varenicline—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000181	0.000233	CcSEcCtD
Varenicline—Urticaria—Ramipril—type 2 diabetes mellitus	0.00018	0.000232	CcSEcCtD
Varenicline—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000179	0.000231	CcSEcCtD
Varenicline—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000179	0.000231	CcSEcCtD
Varenicline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000179	0.00023	CcSEcCtD
Varenicline—Rash—Irbesartan—type 2 diabetes mellitus	0.000177	0.000228	CcSEcCtD
Varenicline—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000177	0.000228	CcSEcCtD
Varenicline—Nausea—Metformin—type 2 diabetes mellitus	0.000177	0.000227	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000177	0.00121	CbGpPWpGaD
Varenicline—Headache—Irbesartan—type 2 diabetes mellitus	0.000176	0.000226	CcSEcCtD
Varenicline—Dizziness—Losartan—type 2 diabetes mellitus	0.000175	0.000225	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	0.00017	0.00117	CbGpPWpGaD
Varenicline—Vomiting—Losartan—type 2 diabetes mellitus	0.000168	0.000216	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000168	0.00115	CbGpPWpGaD
Varenicline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000167	0.000215	CcSEcCtD
Varenicline—Nausea—Irbesartan—type 2 diabetes mellitus	0.000167	0.000215	CcSEcCtD
Varenicline—Rash—Losartan—type 2 diabetes mellitus	0.000167	0.000214	CcSEcCtD
Varenicline—Dermatitis—Losartan—type 2 diabetes mellitus	0.000167	0.000214	CcSEcCtD
Varenicline—Headache—Losartan—type 2 diabetes mellitus	0.000166	0.000213	CcSEcCtD
Varenicline—Asthenia—Ramipril—type 2 diabetes mellitus	0.000163	0.000209	CcSEcCtD
Varenicline—Pruritus—Ramipril—type 2 diabetes mellitus	0.00016	0.000206	CcSEcCtD
Varenicline—Nausea—Losartan—type 2 diabetes mellitus	0.000157	0.000202	CcSEcCtD
Varenicline—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000155	0.0002	CcSEcCtD
Varenicline—Dizziness—Ramipril—type 2 diabetes mellitus	0.00015	0.000193	CcSEcCtD
Varenicline—Vomiting—Ramipril—type 2 diabetes mellitus	0.000144	0.000185	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000144	0.000986	CbGpPWpGaD
Varenicline—Rash—Ramipril—type 2 diabetes mellitus	0.000143	0.000184	CcSEcCtD
Varenicline—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000143	0.000184	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000143	0.000976	CbGpPWpGaD
Varenicline—Headache—Ramipril—type 2 diabetes mellitus	0.000142	0.000183	CcSEcCtD
Varenicline—Nausea—Ramipril—type 2 diabetes mellitus	0.000135	0.000173	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000116	0.000796	CbGpPWpGaD
